Johnson & Johnson reported $63M in Interest Expense on Debt for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Abbott ABT:US $ 123M 12M
Amgen AMGN:US $ 281M 4M
Baxter International BAX:US $ 37M 0M
Becton, Dickinson and BDX:US $ 115M 9M
Biogen BIIB:US $ 56.4M 8.3M
Boston Scientific BSX:US $ 86M 4M
Bristol Myers Squibb BMY:US $ 330M 23M
Conmed CNMD:US $ 9.42M 0.93M
Cooper Companies COO:US $ 5.6M 0.5M
Dexcom DXCM:US $ 25.2M 400K
Eli Lilly And LLY:US $ 86.9M 0.9M
Gilead Sciences GILD:US $ 256M 1M
Hill Rom HRC:US $ 15.7M 1.4M
Hologic HOLX:US $ 21.6M 0.3M
Insulet PODD:US $ 16.6M 3M
Integra Lifesciences IART:US $ 13.15M 220K
Medtronic MDT:US $ 137M 5M
Merit Medical Systems MMSI:US $ 1.39M 151K
Novartis NOVN:VX 201M 1000K
Nuvasive NUVA:US $ 4.39M 3.64M
Pfizer PFE:US $ 316M 20M
Regeneron Pharmaceuticals REGN:US $ 14.4M 0.2M
Tandem Diabetes Care TNDM:US $ 1.51M 0M
Teva Pharmaceutical TEVA:IT 240M 1000K
Vertex Pharmaceuticals VRTX:US $ 15.48M 0.2M
Zimmer Biomet Holdings Inc ZBH:US $ 54.7M 2.4M
Zoetis ZTS:US $ 57M 0M